| 摘要 |
Formulations and methods for preventing, inhibiting or controlling metabolic disorder, age-related disease and acute inflammations have been developed. The compositions comprise of bilirubins, bilirubin derivatives, their tetrapyrrolic analogues, tripyrroles, and dipyrroles. The compositions can be administered as a dosage form for oral ingestion, injection, suppository, or topical application. The effective amount of the compound is typically from 0.001 - 100 mg/kg body weight, preferably in the range from 0.01 - 50 mg/kg body weight, and most preferably from 0.05 - 10 mg/kg body weight. Examples demonstrate the efficacy of the compounds in both in vitro and in vivo tests. |
